State Stem Cell Agency ICOC Agenda 09-09-05

Return to CIRM Meetings and Events

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

California State Stem Cell Agency

 

Regular Meeting of the ICOC to the CIRM

INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE (“ICOC”)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT
 

OPEN SESSION

MEETING STARTS AT 8:30 AM IN HENDRICKS-BAKER RM, TOWER LEVEL 3

  1. Call to Order.
  2. Spotlight Presentation on Alzheimer’s Disease.

MOVE TO CAMELLIA ROOM AT 9:30 AM (Estimated time)

  1. Pledge of Allegiance
  2. Roll Call

    [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]
 

CONSENT ITEMS

  1. Approval of minutes from August 5, 2005 ICOC meeting.
 

REGULAR ITEMS

  1. Chairman’s Report.
  2. President’s Report including, but not limited to:
      a. Informational update on the CIRM Scientific Meeting taking place Oct. 1-2
      b. Consideration of CIRM/ICOC Organizational charts
  3. Consideration of recommendations from Grants Working Group regarding:
      a. Bylaws for Grants Working Group
      b. Procedures for considering grants
      c. Criteria for review of research grant applications
      d. Criteria for award of training grants
      e. Award of training grants
 

CLOSED SESSION

  9.
       a. Pending Litigation (Government Code section 11126, subdivision (e)): People’s Advocate v. Independent

           Citizens’ Oversight Committee, Alameda County Superior Court, Case No. HG05206766; Mary Scott Doe v.
           Robert Klein, et al., U.S. District Court, Central District, Case No. ED CV 05-00438 ; California Family Bioethics
           Council v. California Institute for Regenerative Medicine, Sacramento County Superior Court, Case No.
           05AS02927.

       b. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section
           125290.30(d)(3)(D)).
 

CLOSED SESSION

Immediately prior to restarting the board meeting there will be a brief press conference regarding the Training Grant awards.

  1. Public report of any action taken, if necessary, during closed session.
  2. Consideration of potential second round of funding, including, but not limited to:
      a. Supplementary grants
      b. New grants
      c. Special clinical scholars program grants
  3. Consideration of report from Standards Working Group, including but not limited to:
      a. Consideration of CIRM interim guidelines for human embryonic stem cell research
      b. Appointment of Co-Chair
      c. Consideration of Bylaws for Standards Working Group
      d. Consideration of Standards Working Group Meeting Procedures
  4. Consideration of report from Governance Subcommittee including but not limited to ICOC Bylaws.
    1. Contracts and Interagency Agreement Report
    2. Contracts Summary Balances
    3. CIRM Budget for FY 2005-2006
  5. Informational report on the California Administrative Procedure Act.
  6. Informational session: Ethics Training.
  7. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.
  8. Adjournment.

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 

 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.

 

Date Published: April 6, 2009
Last Modified: April 5, 2017